Mesenchymal Chondrosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-27
Clinical Trial Update: Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma [Phase 2]
A Phase 2 clinical trial of Trabectedin for advanced rearranged mesenchymal chondrosarcoma is currently recruiting.